chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Began feeling pain in bladder and urinary tract the morning of 3/25. Suspected it as a UTI and contacted medical team on 3/26/21. Received prescription for Nitrofurantoin ER (Macrobid) 100mg twice daily for 5 days. As of 4/2/21 at the time of this report, I have completed my course of medication and recovered from the UTI with no additional intervention.
This spontaneous report was received from a physician via a company representative and refers to a 68-year-old female patient with tinnitus and baseline hearing loss for which the patient was a hearing aid user. There was no information about the patient's pertinent medical history, concomitant therapies, and drug reactions or allergies. On an unspecified date in January 2017, the patient was vaccinated with a dose of ZOSTAVAX subcutaneously (strength, dose, frequency, anatomical location, lot number, and expiration date were not provided) for prophylaxis reported as prevention of shingles. Since being administered ZOSTAVAX, the patient's hearing loss (deafness) and tinnitus had gotten progressively worse whereby, she sought medical attention through a visit to an ear, nose, and throat doctor (ENT), and two hearing doctors which performed an unspecified test. Additionally, on an unknown date in 2017, the patient experienced swelling of her right arm and she felt her arm warm (feeling hot). It was reported that after 5 days, the patient's arm swelling "went down". It was unknown by the reporter if treatment was given for the adverse events. At the time of reporting, it was unknown whether the patient recovered or not from the events of deafness, feeling hot, and tinnitus. The causal relationship between the adverse events and the therapy with ZOSTAVAX was not reported. Upon internal review, the event of deafness was considered to be medically significant. Additional information has been requested.
Pain starting in the left arm at injection site.  Over one weeks time hs spread to neck and shoulder area.  No inflammation or redness.  Muscle pain and fatigue impacting daily activities.
Follow up to FAERS18694343: Patient received casirivimab instead of intended COVID vaccine.  At 48-hr follow up. patient reported arm soreness.  Patient received COVID vaccine on December 31.
Site: Itching at Injection Site-Mild, Site: Redness at Injection Site-Mild, Systemic: Allergic: Itch Generalized-Mild, Systemic: Allergic: Rash Generalized-Mild, Additional Details: Mom called 08/13 to report of the reaction. Pt went to Urgent Care and was given Benadryl. On 08/14, she reported pt had diarrhea. ADvised mom to take otc Loperamide. As for the 2nd dose, advised her to talked with a provider so pt will be monitored. As of 08/22, pt was prescribed with Epipen to be ready for her 2nd dose.
Extremely dry and painful nose! On and off nose bleed for 3 weeks. Swollen and painful hands for 3 weeks following the vaccine. Also the normal stuff, sore arm, tired for a few days, but that was not a big deal.
Information has been received from a physician concerning a patient who was vaccinated po with a second dose of RotaTeq. Subsequently the patient experienced vomiting. Very little information was provided regarding this adverse experience. The outcome was reported as recovered. There was no product quality complaint. This is one report of several from the same source. Additional information has been requested.
febrile seizure 8 days p/receiving MMR & HIBtiter vax;
Aches and pain in the left arm; Felt achy and tender; Felt achy and tender; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Aches and pain in the left arm), PAIN (Felt achy and tender) and TENDERNESS (Felt achy and tender) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030L20A, 013M20A and 071F21A) for COVID-19 vaccination.     Concomitant products included LOSARTAN, ATORVASTATIN, HYDROCHLOROTHIAZIDE, AMLODIPINE, GABAPENTIN, METFORMIN and ASPIRIN [ACETYLSALICYLIC ACID] for an unknown indication.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Aches and pain in the left arm), PAIN (Felt achy and tender) and TENDERNESS (Felt achy and tender). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) for Adverse event, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Aches and pain in the left arm) had resolved and PAIN (Felt achy and tender) and TENDERNESS (Felt achy and tender) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The patient experienced aches and pain in the left arm which resolved within two days. The pain in the arm returned 2 weeks later, felt achy and tender. The side effect was ongoing.
Swelling at the injection site; Redness at the injection site; Itching at the injection site; Has a small place on her foot in which it looks like she is getting a hive or rash/ rash on her foot; This is a spontaneous report from a Pfizer-sponsored program. A contactable (age: 79; Unit: unknown) female consumer who received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on an unspecified date in 23Feb2021 as DOSE 2, SINGLE for covid-19 immunization. Historical vaccine included received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, lot number and expiry date were not reported) via an unspecified route of administration on an unspecified date as single dose for covid-19 immunization. Medical history she used to having allergic reactions and she has a history of swelling, done this for years. She has been prescribed an Epipen that she keeps on hand and she never had to use it. The patient's concomitant medications were not reported. In Feb2021, she was experiencing redness, swelling, itching at the injection site, and has a small place on her foot in which it looks like rash. She has been prescribed with an Epipen that she kept on hand and she never had to use it. Reporter asked if she can take an antihistamine that she has on hand and wanted to know if it will interfere with the vaccine. The reporter considered the events as non-serious. The outcome of events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
feels drained; he felt drugged; brain fog; Headache; congestion; Felt like he was catching a cold; Body aches; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (Felt like he was catching a cold), PAIN (Body aches), HEADACHE (Headache), NASAL CONGESTION (congestion) and FEELING ABNORMAL (brain fog) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.    On 07-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 2 dosage form. On 07-Mar-2021, the patient experienced NASOPHARYNGITIS (Felt like he was catching a cold) and PAIN (Body aches). On 08-Mar-2021, the patient experienced HEADACHE (Headache) and NASAL CONGESTION (congestion). On 09-Mar-2021, the patient experienced FEELING ABNORMAL (brain fog). On an unknown date, the patient experienced FATIGUE (feels drained) and FEELING ABNORMAL (he felt drugged). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form once a day and IBUPROFEN (ADVEL) at a dose of 1 dosage form once a day. On 08-Mar-2021, HEADACHE (Headache) and NASAL CONGESTION (congestion) had resolved. At the time of the report, NASOPHARYNGITIS (Felt like he was catching a cold), PAIN (Body aches) and FEELING ABNORMAL (brain fog) was resolving and FATIGUE (feels drained) and FEELING ABNORMAL (he felt drugged) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The Patient received treatment information includes Tylenol and Advil(Ibuprofen) .   Most recent FOLLOW-UP information incorporated above includes: On 15-Mar-2021: A follow up case was received on 15-MAR-2021. Patient demographic details were added.  Product information was added. Events are updated.
This case was reported by a other health professional and described the occurrence of inappropriate age at vaccine administration in a 16-month-old male patient who received BOOSTRIX (batch number N2K27, expiry date 1st October 2015). On 24th September 2014, the patient received BOOSTRIX. On 24th September 2014, an unknown date after receiving BOOSTRIX, the patient experienced inappropriate age at vaccine administration, wrong vaccine administered and underdose. On an unknown date, the outcome of the inappropriate age at vaccine administration, wrong vaccine administered and underdose were unknown. It was unknown if the reporter considered the inappropriate age at vaccine administration, wrong vaccine administered and underdose to be related to BOOSTRIX. Additional information: BOOSTRIX vaccine was accidentally administered to two 16 month old twins. No adverse event reported.
Information has been received from a registered nurse via a mother concerning her son who was vaccinated on an unknown date with one dose of varicella virus vaccine live (Oka/Merck). On an unspecified date, post vaccination, the patient's mother "thinks" the patient had chickenpox. At the time of the report the patient's status was unknown. A product quality complaint was not involved. This is one of two reports received from the same source. Additional information has been requested.
He came to the hospital on 2/12/22 with a chief complaint of generalized weakness for 10 days.  Initial COVID-19 test was positive about 10 days ago.  Patient came to the hospital according to him to make sure he still does not have any COVID-19 infection.  He did have some cough and mucus production without any hemoptysis and has some exertional shortness of breath.   Currently he is saturating well on room air.  Had some nausea which is currently resolved.  Denies any vomiting.  Denies any chest pain, palpitations, abdominal pain cough burning or painful urination, diarrhea, loss of taste or smell.     Previously vaccinated Janssen 4/11/21
Sore arm first night. By next day, headache, body aches, swelling at injection site. By next night, had low grade fever and moderate body aches. Difficulty sleeping first night and second night due to injection site swelling, itching, redness, soreness and inflammation. I'm three days out and still have injection site swelling, redness, itching, soreness and inflammation.
Received vaccine on 9/15 and on 9/19 had 2 blister/red spots on left arm and 2 on the right leg.  Reports injection site is red, swollen, and itchy.
This spontaneous report as received from a 39 year old female consumer who was a other health professional regarding herself. Patient reported that when she was younger she received one dose of VARIVAX (Merck) (lot #, dose, route of administration not reported). No concomitant therapy was reported. Recently she found that she does not have immunity to VARIVAX (Merck). So, her healthcare provider recommended that she be vaccinated again with VARIVAX (Merck). She got vaccinated again with VARIVAX (Merck) on 07-FEB-2014. The patient sought medical attention. The outcome of event was unknown. The causality of the event with suspect VARIVAX (Merck) was unknown. This case is linked with 1402USA006201 via same patient link. This case is related with 1402USA006289 via same reporter link. Additional information has been requested.
This spontaneous report was received from a registered nurse refers to a 2 month old patient of unspecified gender. Patient's medical history, concurrent conditions and drug reactions/allergies were not reported. On 05-OCT-2015 the patient was vaccinated with dose 1 of VAQTA (strength, dose, frequency, route, lot #, expiry date unspecified). No concomitant medications were reported. No adverse symptoms were reported. Additional information has been requested.
swollen gland  on neck; This spontaneous case was reported by a patient and describes the occurrence of LYMPHADENOPATHY (swollen gland  on neck) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced LYMPHADENOPATHY (swollen gland  on neck). At the time of the report, LYMPHADENOPATHY (swollen gland  on neck) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       no concomitant medications reported. no treatment details reported.
Vasovagal episode after receiving influenza and PPD. Referred to ED and released to duty.
Patient felt sick; She has lost a lot of hair since she received the first dose of the Moderna Covid-19 vaccines; Patient had a fever; Sore right injection site arm; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Patient felt sick), ALOPECIA (She has lost a lot of hair since she received the first dose of the Moderna Covid-19 vaccines), PYREXIA (Patient had a fever) and VACCINATION SITE PAIN (Sore right injection site arm) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Jan-2021, the patient experienced MALAISE (Patient felt sick), ALOPECIA (She has lost a lot of hair since she received the first dose of the Moderna Covid-19 vaccines), PYREXIA (Patient had a fever) and VACCINATION SITE PAIN (Sore right injection site arm). At the time of the report, MALAISE (Patient felt sick), ALOPECIA (She has lost a lot of hair since she received the first dose of the Moderna Covid-19 vaccines), PYREXIA (Patient had a fever) and VACCINATION SITE PAIN (Sore right injection site arm) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No concomitant medications information was reported. No treatment medications were provided.   This case was linked to MOD-2022-545585, MOD-2022-54564.   Most recent FOLLOW-UP information incorporated above includes: On 20-Apr-2022: Follow-up received contains no new information.
Developed dizziness, weakness and increase in heart rate on the day of the vaccination. Symptoms resolved after 2 days
Increasing frequent heart palpitations and cardiac arrythmias, and becoming so bad, I went to the local urgent care on Oct. 18 at 2:30 AM. The Dr. thought it might be due to an electrolyte imbalance. I tried to go to work Saturday morning, and after an hour commute, was only able to stay a few minutes as my heart was racing uncontrollably. The blood results were called in to me this morning and it said my TSH was almost 100 and I need to see an Endocrinologist ASAP.
This spontaneous report was received from a office manager and refers to a patient of unknown age and gender. The patient's pertinent medical history, drug reaction/allergies or concomitant medication were not reported. On 20-DEC-2016, the patient was vaccinated with improperly stored dose of ROTATEQ orally, lot # M029251, expiration date: 14-MAR-2018 (dose schedule was not provided) for prophylaxis. There were no adverse effects reported. The administered dose of vaccine experienced a temperature of 48 Fahrenheit for 1 hour. Data logger was involved and there was no previous temperature excursion reported. Additional information has been requested.
HEADACHE,FEELING SICK,PAIN ON SHOULDER,PAIN ALL OVER THE BODY AND TWO EPISODE OF VOMITING.
Pt recvd 3 Hep B vax recvd 3AUG89, 13SEP89, & 29JAN90 on 17FEB89 titer=114; p/ 1 yr titer=5; pt given a 4th dose of vax on 17APR91;following this, titer=174;
Pt said she woke up this morning around 0930  with a mild headache and a swollen bottom lip only on left side of lip. She said her left cheek was tingling. Pt called her PCP APRN but she was out of the office today and her nurse told pt to try some Benadryl. Pt took Benadryl around 1145 and the swelling and tingling was gone by 1230. Pts PCP is supposed to email her regarding if she thinks pt can have second dose or not. Pt denies having any other symptoms.
Petechial rash all over face that occurred within 15 minutes of vaccine.  No difficulty breathing, vomiting or wheezing.  No rash on another part of the body other than rash that was present when she came in.  Had normal respiratory rate and O2 sats of 98%, even after 20 minutes of observation.
later afternoon on day vax given pt had gen malaise, fever & vomiting; tx w/APAP; vomiting cont  thru noc into next AM; mom states will take to pvt MD; MD stated pt had virus
brain bleed; serious fall; Stomach ache; Arm ache; Headaches; Muscle ache; This spontaneous case was reported by a consumer and describes the occurrence of CEREBRAL HAEMORRHAGE (brain bleed) and FALL (serious fall) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 21-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Feb-2021, the patient experienced ABDOMINAL PAIN UPPER (Stomach ache), PAIN IN EXTREMITY (Arm ache), HEADACHE (Headaches) and MYALGIA (Muscle ache). On an unknown date, the patient experienced CEREBRAL HAEMORRHAGE (brain bleed) (seriousness criteria hospitalization and medically significant) and FALL (serious fall) (seriousness criterion hospitalization). At the time of the report, CEREBRAL HAEMORRHAGE (brain bleed), FALL (serious fall), ABDOMINAL PAIN UPPER (Stomach ache), PAIN IN EXTREMITY (Arm ache), HEADACHE (Headaches) and MYALGIA (Muscle ache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment details was reported. No concomitant medication was reported.  Company comment: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded. Patient's elderly age is a risk factor for fall which could have lead to the cerebral hemorrhage. No further information is available.   Most recent FOLLOW-UP information incorporated above includes: On 16-Jul-2021: Follow up received wherein brain bleed and fall events were added and case upgraded to serious On 16-Jul-2021: Upon internal review on 16-SEP-2022 non significant corrections performed to update case received from field; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded. Patient's elderly age is a risk factor for fall which could have lead to the cerebral hemorrhage. No further information is available.
Severe lower jaw and eye spasms, fever, body aches treated at hospital. Hyponatremia, tremors of nervous system
Felt like I had a 36 hour flu; This case was reported by a consumer via interactive digital media and described the occurrence of influenza-like symptoms in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine at an unknown dose. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced influenza-like symptoms. On an unknown date, the outcome of the influenza-like symptoms was recovered/resolved.   It was unknown if the reporter considered the influenza-like symptoms to be related to Shingles vaccine.  Additional case details were reported as follows: The age at vaccination was not reported. The patient received shingles vaccine for a couple days and felt like had a 36 hour flu, at least was forewarned about it. Better than shingles itself.
VERY TIRED THEN 2 DAYS LATER STARTING HAVING EXTREME ABDOMINAL CRAMPING WHICH THEN TURNED INTO DIVERTICULITIS THE NEXT DAY.
Had hart pain, chest pain, pain on back  where hart is, left shoulders and left hand pain . The pain was for 4-5 hours. Had to go to bed. Had to take nitroglycerin.
This spontaneous report was received from a registered pharmacist refers to a 65 years old female patient who about a month ago, in June 2012, was vaccinated subcutaneously with a 0.5 ml dose of ZOSTAVAX (lot number not reported). No other co-suspects were reported. No concomitant medications were reported. The pharmacist reported that about a month ago, in June 2012, the patient came back to see the pharmacist after she had gotten the vaccine because the back of the arm and the armpit of the arm where she was vaccinated in were swollen and red. No treatment information was reported. At the time of the report, the patient's outcome was unknown. The relatedness for back of the arm and the armpit of the arm swollen and red was unknown for ZOSTAVAX. This is one of several reports from the same source. Additional information has been requested.
14 day after the vaccine had worsening of arthritis, before patient could walk and performed daily activities of living. Now patient needs walker and cannot shower on her own. Increase join pain in hands not able to knit anymore.
Significant insomnia overnight, some coughing overnight, shortness of breath/tightness in chest the following day
Patient under the age of 18, given 0.25mL of the Moderna vaccine.
Information was received on 06-OCT-2017 from a lawyer regarding a case in litigation concerning a female patient of unknown age. The patient was inoculated with a dose of ZOSTAVAX vaccine on or about 17-DEC-2008, at a drug store, as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. On or about 05-JUL-2011, the patient was treated by a physician for the onset of a severe vesicular rash accompanied by weakened immune symptoms which was diagnosed as severe herpes zoster, or shingles. On or about 15-JUL-2011, the patient received subsequent treatment by a physician for ongoing symptoms of shingles breaking out on new areas of her arms. The patient has been prescribed FAMVIR for management of her painful symptoms. As a direct and proximate result of these malfunctions, the patient has suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses and pain and suffering and other damages. Additional information has been requested.
pt felt dizzy and hot after receiving immunizations. about 15mins post admin. was managed on site with cold towels and water later